Related Articles
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells
Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines
Antitumor activity of IHL-305, a novel pegylated liposome containing irinotecan, in human xenograft models
(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression
Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.